ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,831, issued on June 30, was assigned to URTESTE S.A. (Gdansk, Poland).
"Diagnostic marker for pancreatic cancer" was invented by Adam Lesner (Gdansk, Poland) and Natalia Gruba (Keblowo, Poland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a compound characterized by formula (1): X1-Thr-Thr-Ala-Arg-X2, wherein cleavage of the compound into a fragment 1 comprising X1 and a fragment 2 comprising X2 generates a detectable signal. The invention further provides an in vitro method for detecting protease activity in a subject's body fluid, comprising contacting the body fluid with the compound of the invention and detecting a signal...